Dose-limiting dermatological toxicity secondary to imatinib mesylate (STI571) in chronic myeloid leukaemia

D Milojkovic, K Short, J R Salisbury, D Creamer, A W P du Vivier, G J Mufti

    Research output: Contribution to journalLetterpeer-review

    9 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1414 - 1416
    Number of pages3
    JournalLeukemia
    Volume17
    Issue number7
    DOIs
    Publication statusPublished - 1 Jul 2003

    Cite this